ETFs Holding RGDO »    RGDO Historical Stock Prices »
RGDO News Video: Thu, Apr 10, 2014, 2:38 PM — Thursday Sector Laggards: Biotechnology, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tobira Therapeutics is a development stage biopharmaceutical company focused on the discovery and development of actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications. Co. is engaged in the discovery and development of two-component drug systems consisting of a therapeutic aptamer and its specific active control agent. Co.'s primary product candidate, REG1, consists of pegnivacogin, a highly potent and selective anticoagulant, and anivamersen, its specific active control agent. Co. is developing REG1 as an anticoagulant for use in patients with a variety of cardiovascular conditions undergoing percutaneous coronary intervention. Self directed investors in Tobira Therapeutics Inc will be interested in keeping up with all Tobira Therapeutics Inc news they can find, both RGDO news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on RGDO. At RediNews, we simplify this task by presenting both RGDO news releases originating from Tobira Therapeutics Inc itself, and RGDO news from a variety of media outlets. Visitors can browse this news online and through our RGDO RSS news feed.


RGDO News — Articles, Videos, & Press Releases

RGDO is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

AIQ News

RediNews invites you to integrate our free RSS news feeds. While web portal content experience like building out an investor relations web site is a major plus when working with our RSS feeds, you don't need stock quote feed experience to begin working with something as simple as RSS — which stands for Really Simple Syndication. Although such experience could lead to some great custom market content ideas like a custom stock ticker with related news included, you don't need to be at the level of head of IR content for an IR services firm to work with our feeds. And unlike investor relations data feeds that typically carry steep licensing feeds, our RediNews RSS feeds are provided to you free of charge. To give our feeds a try, look for the RSS icon for any news page (which will look like this): .

RGDO News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.